Navigation Links
Towards a natural pacemaker
Date:4/9/2009

Artificial heart pacemakers have saved and extended the lives of thousands of people, but they have their shortcomings such as a fixed pulse rate and a limited life. Could a permanent biological solution be possible?

Richard Robinson and colleagues at New York's Columbia and Stony Brook Universities certainly think so, and their work published in the latest issue of The Journal of Physiology brings the dream a step closer to reality.

The body's own natural pacemaker, called the sinoatrial (SA) node, is extremely vulnerable to damage during a heart attack, often leaving the patient with a weak, slow or unreliable heartbeat. The heart has limited ability to recover from the damage, so the conventional approach is to fit an electronic device to monitor and control the beat directly.

Therapies to help raise the heart rate biologically could be a much better solution, but there are some major hurdles. The way electrical signals are generated in the SA node and hence the heart rate are far from simple. There are three separate electrical pathways between cells, called HCN or 'funny' channels (because of their complex behaviour), that could be involved.

Dr Robinson's work helps to shed light on the secrets of the HCN channels, but more importantly describes a cell culture they have developed that accurately mimics HCN function in whole mammalian hearts, making future research in the area far quicker and easier.

The researchers used their new cellular model to genetically 'rewire' two of the HCN channels. The resulting heart rate was very rapid with irregular pauses, just as has already been observed in dogs and mice.

It is early days but the valuable new computer and cellular models are ideal for testing potential new drugs to influence heart rate and pave the way for new genetic biological pacemakers to be developed.

Dr Robinson commented that the new developments "will facilitate the development of practical biological pacemakers by allowing more complete and rapid assessment of individual channel mutations through combined culture and simulation studies prior to full testing in animal models."


'/>"/>

Contact: Melanie Thomson
melanie.thomson@wiley.com
44-186-547-6270
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. Cancer: Another step towards medication
2. Oceans journey towards the center of the Earth
3. Attitudes towards assisted reproduction and preimplantation genetic diagnosis
4. Scientists announce major progress towards historic Census of Marine Life in 2010
5. Researchers take first steps towards spinal cord reconstruction following injury
6. Research points towards early cancer detection
7. New simulation shows consequences of a world without Earths natural sunscreen
8. Synthesizing the most natural of all skin creams
9. A natural approach for HIV vaccine
10. Understanding natural crop defenses
11. Honest crabs, power to the hungry, nice mice and clever meerkats: News from the American Naturalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
(Date:3/21/2016)... , March 22, 2016 ... with passcodes for superior security   ... leading provider of secure digital communications services, today announced ... technology and offer enterprise customers, particularly those in the ... recognition and voice authentication within a mobile app, alongside, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology: